期刊文献+

宫颈细胞学中异常角化细胞的临床风险分析

Clinical risk analysis of abnormal keratinocyte cells in cervical cytology
原文传递
导出
摘要 目的:探讨宫颈细胞学中以异常角化细胞为主要判读细胞的病例的临床风险。方法:对484例细胞学诊断为LSIL的涂片进行回顾性观察,分析其中以异常角化细胞为主要判读细胞的病例,并追踪组织病理学结果。结果:484例细胞学诊断为LSIL的病例中,以异常角化细胞变化为主的病例102例,组织病理结果为:炎症11例,CINI 27例、CINⅡ22例、≥CINⅢ42例,所占比例分别为:10.78%、26.47%、21.57%、41.18%;以其他异常细胞为主要判读细胞的病例382例,组织病理结果为:炎症68例、CINI180例、CINⅡ62例、≥CINⅢ72例,所占比例分别为:17.80%、47.12%、16.23%、18.85%。以异常角化细胞变化为主的病例中的CINⅡ、CINⅢ所占比例要高于以其他异常细胞为主要判读细胞的病例,其中CINⅢ两者相比差异有统计学意义(P<O.01)。405例组织病理结果为CIN的病例中,细胞学以异常角化细胞变化为主的病例所占比例各为CINI13.04%(27/207)、26.20%(22/84)、≥CINⅢ38.53%(42/112),明显呈上升趋势。结论:细胞学诊断为LSIL中,以异常角化细胞变化为主要判读细胞的病例的临床风险明显要高于以其他异常细胞为主要判读细胞的病例,细胞学诊断应加强对这类细胞的识别,而临床应加强对这类病例的管理和随访。 Objective: To explore the clinical risk of abnormal keratinocyte as the main interpretation standards in cervical cytology. Methods: 484 Pap smears with the cytological diagnosis of LSIL were observed retrospectively, and the cases by abnormal keratinoeyte as the main interpretation standards were selected, and their histopathology results were tracked. Results: 102 cases were singled out and the histopathology results were: inflammation (10. 78%, 11/102), CIN I (26.47%, 27/102), CIN Ⅱ (21.57%, 22/102), ≥ CIN m (41.18%, 42/102) . The other 382 cases without the abnormal keratinoeyte showed: inflammation (17. 80%, 68/382) , CIN I (47. 12%, 180/382), CINH (16. 23%, 62/382), ≥CIN $ (18.85%, 72/382) . The proportion of CIN Ⅱ and CIN Ⅲ in cases of abnormal keratinoeyte as the main interpretation standards were higher than those of any other abnormal cells as main interpretation standards, there was significant difference in the proportion of CINⅢ (P 〈 0. 01 ) . In the 405 cases of CIN, the histopathology results with abnormal keratinocyte showed a rising trend form CINI to CINm : CINI 13.04% (27/207), CINⅡ 26. 20% (22/84), ≥CINllI 38.53% (42/112) . Conclusion: In the LSIL cases, the clinical risk with abnormal keratinocyte as the main interpretation standards is significantly higher than that of other abnormal cells. It should be strengthened by the identification of cytological diagnosis, clinical management and follow - up of such cases.
出处 《中国妇幼保健》 CAS 北大核心 2014年第1期23-25,共3页 Maternal and Child Health Care of China
基金 江苏省科技厅社会发展项目〔BE2011806 BE2011807 BS2007080〕
关键词 角化细胞 宫颈涂片 临床风险 Keratinocyte Cervical cytology Clinical risk
  • 相关文献

参考文献5

二级参考文献42

  • 1苏涛,章桂红,程利南.液基薄层细胞学技术在宫颈病变筛查中的应用及评价[J].国外医学(妇产科学分册),2004,31(4):252-255. 被引量:112
  • 2张晓群,黄龙,肖春卫.TBS系统在宫颈细胞学诊断中的应用[J].公共卫生与预防医学,2007,18(1):96-97. 被引量:4
  • 3Chu PG,Weiss LM.Keratin expression in human tissues and neoplasms[J].Histopathology,2002,40:403-39. 被引量:1
  • 4Moll R,Divo M,Langbein L.The human keratins:biology and pathology[J].Histochem Cell Biol,2008,129:705-33. 被引量:1
  • 5Smedts F,Ramaekers FC,Vooijs PG.The dynamics of keratin expression in malignant transformation of cervical epithelium:a review[J].Obsetet Gynecol,1993,82:465-74. 被引量:1
  • 6Nair SA,Nair MB,Jayaprakash PG,et al.Increased expression of cytokeratins 14,18 and 19 correlates with tumor progression in the uterine cervix[J].Pathobiology,1997,65:100-7. 被引量:1
  • 7Maddox P,Sasieni P,Szarewski A,et al.Differential expression of keratins 10,17,and 19 in normal cervical epithelium,cervical intraepithelial neoplasia,and cervical carcinoma[J].J Clin Pathol,1999,52:41-6. 被引量:1
  • 8Ikeda K,Tate G,Suzuki T,et al.Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma:An immunohistochemical analysis and review of the literature[J].Gynecologic Oncology,2008,108:598-602. 被引量:1
  • 9Carrilho C,Alberto M,Buane L,et al.Keratins 8,10,13,and 17 are useful markers in the diagnosis of human cervix carcinomas[J].Hum Pathol,2004,35:546-51. 被引量:1
  • 10Bobrow LG,Makin CA,Law S,et al.Expression of low molecular weight cytokeratin proteins in cervical neoplasia[J].J Pathol,1986,148:135-40. 被引量:1

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部